Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Rubin, David T.

One or more keywords matched the following items that are connected to Rubin, David T.

Item Type	Name
Concept	Remission Induction
Academic Article	Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission.
Academic Article	Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.
Academic Article	Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article	Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
Academic Article	Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
Academic Article	Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
Academic Article	Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Academic Article	Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
Academic Article	Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
Academic Article	Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Academic Article	Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
Academic Article	Vedolizumab in the treatment of Crohn's disease.
Academic Article	Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
Academic Article	Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Academic Article	Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
Academic Article	Long-term Efficacy of Vedolizumab for Crohn's Disease.
Academic Article	Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
Academic Article	Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
Academic Article	The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Academic Article	Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article	Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
Academic Article	Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2.
Academic Article	Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
Academic Article	ACG Clinical Guideline: Ulcerative Colitis in Adults.
Academic Article	Histologic Remission in Ulcerative Colitis: Are We There Yet?
Academic Article	Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Academic Article	Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing.
Academic Article	Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease.
Academic Article	Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
Academic Article	Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
Academic Article	Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
Academic Article	Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
Academic Article	Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.
Academic Article	STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Academic Article	Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
Academic Article	Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Academic Article	Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Academic Article	A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
Academic Article	Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Academic Article	(Re)Appraising Remission in Ulcerative Colitis.
Academic Article	Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
Academic Article	Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease.
Academic Article	Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Academic Article	Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Academic Article	Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
Academic Article	Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.

Search Criteria

Remission Induction